Susquehanna International Group’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $723K | Buy |
250,295
+88,393
| +55% | +$255K | ﹤0.01% | 3792 |
|
|
2025
Q1 | $348K | Buy |
161,902
+94,323
| +140% | +$203K | ﹤0.01% | 4825 |
|
|
2024
Q4 | $262K | Buy |
67,579
+46,722
| +224% | +$181K | ﹤0.01% | 4929 |
|
|
2024
Q3 | $137K | Sell |
20,857
-31,123
| -60% | -$204K | ﹤0.01% | 4998 |
|
|
2024
Q2 | $377K | Sell |
51,980
-6,142
| -11% | -$44.5K | ﹤0.01% | 3906 |
|
|
2024
Q1 | $441K | Buy |
58,122
+47,747
| +460% | +$362K | ﹤0.01% | 3700 |
|
|
2023
Q4 | $47.2K | Buy |
+10,375
| New | +$47.2K | ﹤0.01% | 5554 |
|
|
2023
Q3 | – | Sell |
-12,818
| Closed | -$40.1K | – | 6013 |
|
|
2023
Q2 | $40.1K | Sell |
12,818
-167,135
| -93% | -$523K | ﹤0.01% | 5251 |
|
|
2023
Q1 | $815K | Buy |
+179,953
| New | +$815K | ﹤0.01% | 3185 |
|
|
2022
Q4 | – | Sell |
-15,709
| Closed | -$50K | – | 6377 |
|
|
2022
Q3 | $50K | Buy |
+15,709
| New | +$50K | ﹤0.01% | 5497 |
|
|
2022
Q2 | – | Sell |
-55,366
| Closed | -$224K | – | 6318 |
|
|
2022
Q1 | $224K | Sell |
55,366
-43,974
| -44% | -$178K | ﹤0.01% | 4687 |
|
|
2021
Q4 | $1.07M | Buy |
99,340
+29,523
| +42% | +$319K | ﹤0.01% | 2782 |
|
|
2021
Q3 | $805K | Buy |
+69,817
| New | +$805K | ﹤0.01% | 3033 |
|
|
2021
Q2 | – | Sell |
-18,810
| Closed | -$275K | – | 5675 |
|
|
2021
Q1 | $275K | Buy |
+18,810
| New | +$275K | ﹤0.01% | 4444 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 4811 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 3887 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 4348 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 4115 |
|
|
2018
Q2 | – | Sell |
-8,520
| Closed | -$762K | – | 4225 |
|
|
2018
Q1 | $762K | Buy |
8,520
+7,452
| +698% | +$666K | ﹤0.01% | 1719 |
|
|
2017
Q4 | $59K | Buy |
+1,068
| New | +$59K | ﹤0.01% | 3414 |
|
|
2017
Q3 | – | Sell |
-6,672
| Closed | -$281K | – | 3771 |
|
|
2017
Q2 | $281K | Buy |
6,672
+5,795
| +661% | +$244K | ﹤0.01% | 2821 |
|
|
2017
Q1 | $49K | Sell |
877
-2,646
| -75% | -$148K | ﹤0.01% | 3055 |
|
|
2016
Q4 | $134K | Buy |
3,523
+1,260
| +56% | +$47.9K | ﹤0.01% | 3838 |
|
|
2016
Q3 | $90K | Buy |
2,263
+493
| +28% | +$19.6K | ﹤0.01% | 2714 |
|
|
2016
Q2 | $127K | Sell |
1,770
-3,380
| -66% | -$243K | ﹤0.01% | 2875 |
|
|
2016
Q1 | $413K | Sell |
5,150
-1,871
| -27% | -$150K | ﹤0.01% | 2774 |
|
|
2015
Q4 | $530K | Buy |
7,021
+3,661
| +109% | +$276K | ﹤0.01% | 2932 |
|
|
2015
Q3 | $1.29M | Buy |
3,360
+2,678
| +393% | +$1.03M | ﹤0.01% | 2117 |
|
|
2015
Q2 | $283K | Sell |
682
-14
| -2% | -$5.81K | ﹤0.01% | 3811 |
|
|
2015
Q1 | $331K | Buy |
+696
| New | +$331K | ﹤0.01% | 3392 |
|